脂蛋白关联磷脂酶A2(PLA2G7)检测试剂盒(酶联免疫吸附试验法)

ELISA Kit for Phospholipase A2 Group VII (PLA2G7)

LpPLA2; PAF-AH; PAFAH; Lp-PLA2; LDL-PLA2; Platelet Activating Factor Acetylhydrolase,Plasma; Phospholipase A2,Group VII; LDL-associated phospholipase A2; Phospholipase A2, Lipoprotein Associated

  • 脂蛋白关联磷脂酶A2(PLA2G7)检测试剂盒(酶联免疫吸附试验法) 产品包装(模拟)
  • 脂蛋白关联磷脂酶A2(PLA2G7)检测试剂盒(酶联免疫吸附试验法) 产品包装(模拟)
  • 脂蛋白关联磷脂酶A2(PLA2G7)检测试剂盒(酶联免疫吸附试验法) 实验结果图
  • SEA867Mu.jpg 标准曲线图
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

本试剂盒用于检测脂蛋白关联磷脂酶A2(PLA2G7),经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制,不可能完成对所有相关或相似物质交叉反应检测,因此本试剂盒有可能与未经检测的其它物质有交叉反应。

回收率

分别于定值血清及血浆样本中加入一定量的脂蛋白关联磷脂酶A2(PLA2G7)(加标样品),重复测定并计算其均值,回收率为测定值与理论值的比率。

样本 回收率范围(%) 平均回收率(%)
serum(n=5) 92-102 98
EDTA plasma(n=5) 94-105 99
heparin plasma(n=5) 83-91 87

精密度

精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差:取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次,分别计算不同浓度样本的平均值及SD值。
批间差:选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定,每个样本使用同一试剂盒重复测定8次,分别计算不同浓度样本的平均值及SD值。
批内差: CV<10%
批间差: CV<12%

线性

在定值血清及血浆样本内加入适量的脂蛋白关联磷脂酶A2(PLA2G7),并倍比稀释成1:2,1:4,1:8,1:16的待测样本,线性范围即为稀释后样本中脂蛋白关联磷脂酶A2(PLA2G7)含量的测定值与理论值的比率。

样本 1:2 1:4 1:8 1:16
serum(n=5) 89-97% 89-96% 98-105% 87-103%
EDTA plasma(n=5) 84-99% 93-102% 87-97% 80-93%
heparin plasma(n=5) 78-97% 79-101% 88-96% 83-92%

稳定性

经测定,试剂盒在有效期内按推荐温度保存,其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响,实验室的环境条件需尽量保持一致,尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。

实验流程

1. 实验前标准品、试剂及样本的准备;
2. 加样(标准品及样本)100µL,37°C孵育1小时;
3. 吸弃,加检测溶液A100µL,37°C孵育1小时;
4. 洗板3次;
5. 加检测溶液B100µL,37°C孵育30分钟;
6. 洗板5次;
7. 加TMB底物90µL,37°C孵育10-20分钟;
8. 加终止液50µL,立即450nm读数。

实验原理

将脂蛋白关联磷脂酶A2(PLA2G7)抗体包被于96孔微孔板中,制成固相载体,向微孔中分别加入标准品或标本,其中的脂蛋白关联磷脂酶A2(PLA2G7)与连接于固相载体上的抗体结合,然后加入生物素化的脂蛋白关联磷脂酶A2(PLA2G7)抗体,将未结合的生物素化抗体洗净后,加入HRP标记的亲和素,再次彻底洗涤后加入TMB底物显色。TMB在过氧化物酶的催化下转化成蓝色,并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的脂蛋白关联磷脂酶A2(PLA2G7)呈正相关。用酶标仪在450nm波长下测定吸光度(O.D.值),计算样品浓度。

相关产品

编号 适用物种:Mus musculus (Mouse,小鼠) 应用(仅供研究使用,不用于临床诊断!)
RPA867Mu01 脂蛋白关联磷脂酶A2(PLA2G7)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPA867Mu02 脂蛋白关联磷脂酶A2(PLA2G7)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAA867Mu02 脂蛋白关联磷脂酶A2(PLA2G7)多克隆抗体 WB; IHC; ICC; IP.
PAA867Mu01 脂蛋白关联磷脂酶A2(PLA2G7)多克隆抗体 WB; IHC; ICC; IP.
LAA867Mu81 脂蛋白关联磷脂酶A2(PLA2G7)多克隆抗体(异硫氰酸荧光素标记) WB; IHC; ICC; IF.
LAA867Mu71 脂蛋白关联磷脂酶A2(PLA2G7)多克隆抗体(生物素标记) WB; IHC; ICC.
SEA867Mu 脂蛋白关联磷脂酶A2(PLA2G7)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.

参考文献

杂志 参考文献
Science & Sports The effects of different intensity walking programs on serum blood lipids, high-sensitive C-reactive protein, and lipoprotein-associated phospholipase A2 in premenopausal women [ScienceDirect: S0765159710000262]
Metabolic Syndrome and Related Disorders Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease [Wiley: source]
34 Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study [PubMed: 22240497]
PLoS ONE Effects of Lipid-Lowering Drugs on Irisin in Human Subjects In Vivo and in Human Skeletal Muscle Cells Ex Vivo [PubMed: PMC3759413]
China Pharmacy Influence of Tongfengtai Granules on Inflammatory Factor in Acute Gouty Arthritis Model Rats [Source]
Atherosclerosis Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients. [Pubmed: 23958269]
Journal of Diabetes Research Lipoprotein-Associated Phospholipase A2 Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus [Hindawi: 278063]
Health The Role of Asymmetric Dimethylarginine and Lipoprotein Associated Phospholipase A2 in Children and Adolescents with Dyslipidemia [Scirp:Source]
Biology Bulletin In vitro lipid-lowering and fibrinolytic effects of regulatory leucine-containing glyprolines in human blood [Springer:Source]
Gynecol Endocrinol. Lipoprotein-associated phospholipase A2 and AGEs are associated with cardiovascular risk factors in women with history of gestational diabetes mellitus. [Pubmed:24397392]
Journal of Diabetes Research Lipoprotein-Associated Phospholipase A 2 Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus [Pubmed:24818163]
Metabolism. Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetes [Pubmed:25034387]
J Am Heart Assoc Effect of Extended‐Release Niacin on High‐Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin‐Treated Patients [PubMed: 26374297]
Czecho-Slovak Dermatology / Cesko-Slovenska Dermatologie V [Ebscohost]
Endocrinol Metab (Seoul). Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA2?in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome [pmc:PMC4803547]
Clin Pharmacol Ther.? Effect of dipyridamole on myocardial reperfusion injury: A double‐blind randomized controlled trial in patients undergoing elective coronary artery bypass surgery [Pubmed:25773594]
Lipids in Health and Disease Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A 2 and secretory phospholipase A 2 in patients with newly … [articles:10.1186]
Acta Endocrinologica SERUM LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN MALES WITH METABOLIC SYNDROME AND OBSTRUCTIVE SLEEP APNEA. [jrnl:1841098]
Biomarker for diagnosis of moyamoya disease [:]
留言咨询
幸运飞艇投注 应用必备| 彰化市| 油尖旺区| 布拖县| 高密市| 株洲采购| 江安县| 张家港市| 舟曲县| 金乡县| 桑日县| 安装信息| 南宁市| 巍山| 武城县| 监利县| 云阳县| 柳州市政府采购网| 含山县| 林芝县| 东兰县| 平乐县| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>|